Skip to content

Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19

Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
LBCTR
Registry ID
LBCTR2021044780
Enrollment
90
Registered
2021-04-18
Start date
2021-04-19
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19/ Practical and safe diagnostic tools COVID-19

Interventions

From each enrolled participant are collected: 1 nasopharyngeal swab, 1 lingual swab, 1 sublingual swab and 1 oropharyngeal spitted saliva.
Nasopharyngeal swab + salivary swab from tongue dorsal surface+sublingual salivary swab+oropharyngeal spitted saliva are collected from each participant
COVID-19
salivary swabs

Sponsors

Lebanese University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. COVID-19 Positive Tested Patients from all nationalities, presenting mild or moderate cases (not intubated and not under oxygen). 2. Patients whom (or guardians) give written informed consent.

Exclusion criteria

Exclusion criteria: 1. COVID-19 Positive tested patients presenting disabilities (Mental retardation-Physical invalidity-Psychological,troubles- Cognitive troubles affecting the capacity of discernation). 2. Patients presenting hyposalivation. 3. Patients whom (or guardians) decline written informed consent.

Design outcomes

Primary

MeasureTime frame
Name: To detect the efficacy of oral swabs and oropharyngeal spitted saliva as a diagnostic tool for the COVID-19.;Timepoints: End of study;Measure: Salivary SARS-CoV-2 Ct from salivary swabs

Secondary

MeasureTime frame
Name: To compare Salivary SARS-CoV-2 (from lingual,sublingual and oropharyngeal spitted saliva) cycle threshold (Ct) to nasopharyngeal SARS-CoV-2 Ct ;Timepoints: End of study;Measure: Nasophayngeal SARS-CoV-2 Ct

Countries

Lebanon

Contacts

Public ContactRola EL-ZEIN

Lebanese University

roulaelzein@ul.edu.lb009613252480

Outcome results

None listed

Source: LBCTR (via WHO ICTRP) · Data processed: Feb 7, 2026